Eurie Hong

Title: Eurie Hong: Innovator in Biomarker Research

Introduction

Eurie Hong is a prominent inventor based in Mountain View, CA. He has made significant contributions to the field of biomarker research, particularly in the context of regulatory dysfunction in diseases. His innovative work has the potential to enhance diagnostic methods and disease risk profiling.

Latest Patents

Eurie Hong holds a patent titled "Method and system for the use of biomarkers for regulatory dysfunction in disease." This patent focuses on measuring the binding of a transcription factor, utilizing techniques such as chromatin immunoprecipitation. The invention provides an improved marker for diseases where transcription factor binding events are critical. These biomarkers can be instrumental in diagnostics and can also help adjust disease risk profiles for healthy individuals, similar to typical genetic variants. He has 1 patent to his name.

Career Highlights

Eurie Hong is affiliated with Leland Stanford Junior University, where he continues to advance his research in biomarker applications. His work is recognized for its potential impact on understanding and diagnosing various diseases.

Collaborations

Eurie collaborates with notable colleagues, including Konrad Karczewski and Michael P. Snyder. Their combined expertise contributes to the innovative research environment at their institution.

Conclusion

Eurie Hong's contributions to biomarker research exemplify the intersection of innovation and healthcare. His work not only enhances diagnostic capabilities but also paves the way for personalized medicine approaches.